Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)
Status:
Completed
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
We hypothesize that individuals with Alpha-1 Antitrypsin (AAT) deficiency have ongoing liver
injury which is not detected by the usual blood tests used to look at liver function. This
ongoing liver injury leads to cirrhosis in a significant number of adults with AAT
deficiency.
Details
Lead Sponsor:
University of Florida
Treatments:
Acetaminophen Acetaminophen, hydrocodone drug combination Alpha 1-Antitrypsin Fentanyl Lidocaine Liver Extracts Lorazepam Midazolam Ondansetron Oxycodone Protein C Inhibitor